Outcomes with Hypomethylating Agent and Venetoclax Combination in Patients with TP53-mutated Myelodysplastic Syndromes
Authors:
- Michael CanonicoMCMichael Canonico
- Parth PatelPPParth Patel
- Najhla H Al AliNANajhla H Al Ali
- Ashwin KishtagariAKAshwin Kishtagari
- Kateryna FedorovKFKateryna Fedorov
- Laura A. LeeLLLaura A. Lee
- Sanjay MohanSMSanjay Mohan
- Rami KomrokjiRKRami Komrokji
- Emily MasonEMEmily Mason
- Michael R SavonaMSMichael R Savona
- David SallmanDSDavid Sallman
- Somedeb BallSBSomedeb Ball
Open Access
- 28 September 2026
- journal article
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2